Cash Ratio Analysis of BioCryst Pharmaceuticals Inc - Deep Dive


Cash Ratio of BCRX
Dec-23
0.738
Not Good Cash Ratio
Dec-22
4.02
Very Good Cash Ratio
Growth
-81.66
%
Cash Ratio Analysis of BioCryst Pharmaceuticals Inc
Cash Ratio of BCRX drastically fell by -81.66 % this year.
Cash Ratio with value of 4.89 was highest in Year Dec-21 in last Five Years.
Cash Ratio with value of 0.738 was lowest in Year Dec-23 in last Five Years.
Latest Cash Ratio with value of 0.738 is lower than Average Cash Ratio of 2.79 in last five years.
Other Cash Ratio Related Info of BCRX that may interest you.
BioCryst Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
BCRX6.246.17 1.13 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents.   more ..
Cash Ratio Formula

Cash Ratio Related Ratios
CurrentRatioQuickRatioDebtToEquityRatio

Tsr Stability Index
Poor Stability Stock
FY - Historical Cash Ratio of BioCryst Pharmaceuticals Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Cash Ratio0.7384.024.892.841.481.501.53
Change-81.66 %-17.83 %72.15 %92.70 %-1.88 %-1.64 %52.05 %
You are view first 7 Records. Log in to view all 30 in Premium view
FY Chart of Cash Ratio of BioCryst Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)